Skip to content

BIO ESSENCE CORP.: 10-Q filed 2026-08-14

What BIO ESSENCE CORP. reported in its quarterly report filed 2026-08-14 (fiscal Q2 2026): 39 published measures, 105 facts as tagged in accession 0001213900-26-090174.

This filing

Form
10-Q (quarterly report)
Filed
2026-08-14
Fiscal period
fiscal Q2 2026
Accession
0001213900-26-090174 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIO ESSENCE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-304,002,945USD
At 2025-12-31422,474USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-301,660,388USD
At 2025-12-312,495,367USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-302,342,557USD
At 2026-03-31-1,427,520USD
At 2025-12-31-2,072,893USD
At 2025-06-30-3,114,978USD
At 2025-03-31-3,174,842USD
At 2024-12-31-2,969,090USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30270,077USD91
2026-01-01 to 2026-06-30475,450USD181
2026-01-01 to 2026-03-31205,373USD90
2025-04-01 to 2025-06-3059,864USD91
2025-01-01 to 2025-06-30-145,888USD181
2025-01-01 to 2025-03-31-205,752USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-352,320USD181
2025-01-01 to 2025-06-30141,728USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2026-04-01 to 2026-06-30794,711USD91
2026-01-01 to 2026-06-301,295,248USD181
2025-04-01 to 2025-06-30259,123USD91
2025-01-01 to 2025-06-30281,312USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2026-01-01 to 2026-06-30437,822USD181
2025-01-01 to 2025-06-30-143,099USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-84,827USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2026-06-30-9,077,623USD
At 2025-12-31-9,553,073USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2026-04-01 to 2026-06-3050,885,923shares91
2026-01-01 to 2026-06-3047,934,967shares181
2025-04-01 to 2025-06-3038,009,000shares91
2025-01-01 to 2025-06-3038,009,000shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2026-04-01 to 2026-06-3010,411USD91
2026-01-01 to 2026-06-3020,250USD181
2025-04-01 to 2025-06-30800USD91
2025-01-01 to 2025-06-30800USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2026-04-01 to 2026-06-30279,290USD91
2026-01-01 to 2026-06-30495,085USD181
2025-04-01 to 2025-06-3061,223USD91
2025-01-01 to 2025-06-30-143,869USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-30606,507USD
At 2025-12-31422,377USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-301,605,031USD
At 2025-12-312,439,211USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-12-3147,879USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-12-3197USD
At 2025-06-303,396,438USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-12-3123,454USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2026-04-01 to 2026-06-30190,971USD91
2026-01-01 to 2026-06-30294,529USD181
2025-04-01 to 2025-06-30107,421USD91
2025-01-01 to 2025-06-30333,101USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30470,261USD91
2026-01-01 to 2026-06-30789,614USD181
2025-04-01 to 2025-06-30168,644USD91
2025-01-01 to 2025-06-30189,232USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2026-04-01 to 2026-06-30324,450USD91
2026-01-01 to 2026-06-30505,634USD181
2025-04-01 to 2025-06-3090,479USD91
2025-01-01 to 2025-06-3092,080USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2026-06-3053,809,000shares
At 2025-12-3138,009,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2026-06-30675USD
At 2024-12-311,371USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-3011,414,799USD
At 2025-12-317,476,379USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2026-06-301,500,000USD
At 2025-12-311,500,000USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2026-06-3056,836USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2026-06-303,396,438USD
At 2025-12-3197USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2026-06-30122,950USD
At 2025-12-313,750USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2026-04-01 to 2026-06-30280,488USD91
2026-01-01 to 2026-06-30495,700USD181
2025-04-01 to 2025-06-3060,664USD91
2025-01-01 to 2025-06-30-145,088USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2026-04-01 to 2026-06-30190,971USD91
2026-01-01 to 2026-06-30293,849USD181
2025-04-01 to 2025-06-30107,421USD91
2025-01-01 to 2025-06-30303,158USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2026-04-01 to 2026-06-30103,659USD91
2026-01-01 to 2026-06-30103,659USD181
2025-04-01 to 2025-06-3059USD91
2025-01-01 to 2025-06-30117USD181

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2026-04-01 to 2026-06-30-2,342USD91
2026-01-01 to 2026-06-30-1,800USD181
2025-04-01 to 2025-06-30547USD91
2025-01-01 to 2025-06-301,090USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2026-04-01 to 2026-06-301,198USD91
2026-01-01 to 2026-06-30615USD181
2025-04-01 to 2025-06-30-559USD91
2025-01-01 to 2025-06-30-1,219USD181

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2026-04-01 to 2026-06-3010,411USD91
2026-01-01 to 2026-06-3020,250USD181
2025-04-01 to 2025-06-30-800USD91
2025-01-01 to 2025-06-30800USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2026-01-01 to 2026-06-301,082USD181
2025-01-01 to 2025-06-301,090USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2026-01-01 to 2026-06-3010,416USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2026-01-01 to 2026-06-30440,000USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-01-01 to 2025-12-311,500,000USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-23,454USD181
2025-01-01 to 2025-06-30-155USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2026-01-01 to 2026-06-30-47,880USD181
2025-01-01 to 2025-06-30-7,046USD181

Inspect the source

Entity
BIO ESSENCE CORP. / CIK 0001723059
Captured
2026-09-21T17:27:22.070Z
SEC response SHA-256
c565ac0ada9acac433d9d3ce0585ef488a941f4edaa321f84fc2ccaeabe2c67c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001723059.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))